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Background and aim: The new pacemaker (PM) generations featuring
extended memory functions (MF) document the occurrence of arrhythmias
over periods of several months.  Recordings of all atrial episodes and their
characteristics contribute to the efficacious treatment of these patients.  How-
ever, ventricular arrhythmia (VA) characteristics and occurrences are less
well-known in this population.  The goal of this study was to evaluate the per-
tinence of MF at the ventricular level and to describe the MF-documented
VAs.
Methods & Results: the study involved  a  continuous series of 93 pts (M
66%, aged 75±10 yrs) implanted with SC or DC Kappa and EnPulse PMs
(Medtronic, MN, USA) for AVB 41%, SD 55%.  497 visits were analyzed
(follow-up at 7 months avg.) over a period from 2 to 81 months after implan-
tation, and occurrences of VA validated by EGMs, defined by at least 5 QRS
complexes >175/mn.  The number of episodes and the duration and heart rate
during the longest arrhythmia episodes were recorded.  24 pts (26%) average
ages 74 ± 13 yrs of whom 78% males, showed ventricular arrhythmias in 88
visits (18%).  The average number of episodes was 9 per follow-up (1-140),
average duration was 4 ±4 seconds (1-27 sec), and average rate was 214 ± 33
bpm. (174-307). The totality of the episodes were classified as non-sustained
ventricular tachycardia (NSVT).  The ejection fraction was 51±11%.  84%
showed cardiopathy : CAD (12), HCM(4) and DCM (4).  Statistical analysis
showed that age, pacing indication, pacing mode and cumulated percentage of
pacing are not relevant factors in NSVT.
Conclusion: VAs are observed in π of pts implanted for standard pacing
indications.  A major determining factor in the occurrence of NSVT is the
presence of an associated cardiopathy.  FMs featuring EGM recordings are a
tool for reliable diagnostic and monitoring of these events.  Further studies are
required to evaluate the prognostic significance of these VAs.  
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We suggested being interested in the theoretical and practical aspect of the
slew-rate measurement, to obtain an evaluation of the relation between this
measure and the other measures done during implantation and follow-up such
as the stimulation thresholds, the value of the EGM and the impedance. The
variation of this parameter will inform us about the quality of the interface
lead/myocardium.
Method: The study recruited 746 patients not selected a priori,
implanted for AV block (51%) or sinus dysfunction (47%). 847 leads were
retained to form 3 homogeneous and comparable groups for their physical,
electric characteristics and their site of implantation for atrial and ventricular
chambers. They correspond to the optimal characteristics (Gr1), acceptable
(Gr2) and not acceptable (Gr3) of sensing and pacing parameters usually
admitted by the literature.
Results: For auricular chamber, we retained a priori, 56 leads (Gr1), 168
for (Gr2) and 15 for (Gr3); the factorial discriminate analysis (FDA) was real-
ized from the variables of slew-rate, sensing per and post-op and threshold per
and post-op gives us a result of 83.7% of individuals good classified.
 For the ventricular chamber, we retained a priori, 183 leads (Gr1), 168 (Gr2)
and 9 (Gr3); the FDA realized from the same variables gives us a result of 80
% of individuals good classified. 
The comparison of the averages between groups for every variable shows a
significant difference between these groups as well as in the atrial and the ven-
tricular chambers. The data of the others leads (atrium n=94 and ventricle
n=154) were affected by the FDA calculation. 
Conclusion: The results shown a correlation between slew-rate and
electric parameters per and post-op for the 3 groups for atrial and ventricular
chambers; a new standard for sensing, pacing and slew-rate values were
defined as optimal, acceptable and no-acceptable.
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Accessory pathway (AP) ablation is the treatment of choice of symptomatic
patients (pts) with a Wolff-Parkinson-White (WPW) syndrome or pts with a
malignant form at electrophysiological study (EPS). WPW  can reappear after
ablation. The purpose of the study was to look for the risk factors of AP reap-
pearance and the clinical consequences.
Methods: AP ablation was performed in 327 pts aged from 8 to 77 years
(37±16), with a WPW. Ablation failed in 6 pts. In other pts, the anterograde
and retrograde conduction disappeared after AP radiofrequency ablation.
Reappearance of AP occurred in 48 pts from several hours to several years.
Their data were studied.
Results: There were no significant clinical differences between pts with
and without reappearance of AF, concerning the age (33±16 years vs 36±16),
the gender (male gender 28/48 vs 166/280), the reason of ablation (sponta-
neous malignant form: 10/48 vs 70/280; spontaneous AV reentrant tachycardia
(AVRT): 29/48 vs 176/280, asymptomatic with electrophysiological signs of
malignancy: 9/48 vs 38/280), the location of AP (left lateral AP: 21/48 vs 125/
280, posteroseptal  AP: 22/47 vs 119/280, anteroseptal: AP 5/47 vs 27/280).
During the follow up, among 9 of 45 pts asymptomatic before ablation but
with only inducible rapid AF at EPS, 2 pts became symptomatic and had
inducible AVRT at the control. 29 of 202 pts with spontaneous AVRT pre-
sented recurrences of AVRT, except one and a 2nd procedure was required.
Among 10 of 79 with syncope and signs of malignancy or spontaneous rapid
AF, 2 pts have lost the signs of malignancy at 2nd EPS; 2 pts who presented
only with rapid AF, had an AP with long refractory period but developed
incessant AVRT’s; 6 pts had still signs of malignancy, requiring a second pro-
cedure.
Conclusions: There was no significant clinical or electrophysiological
cause that explains the reappearance of AP after ablation. The reappearance of
conduction is generally associated with reappearance of all properties of AP
associated with malignancy or AVRT, except in some cases. Pts without
AVRT before ablation may become symptomatic and develop this AVRT after
AP ablation.
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Background: Arrhythmic storm (AS) was defined for the purpose of the
present study as the occurrence of frequent episodes (more than 3/day) of
hemodynamically destabilizing ventricular tachycardia or ventricular fibrilla-
tion requiring immediately electrical cardioversion or defibrillation. The aim
of this study was to determine the prevalence, causes and long-term prognosis
of AS in patients with dilated cardiomyopathy, in whom an ICD was
implanted for primary prevention.
Methods: This observational study compromised 135 pts (114 M, 21 F, 69
±20 years old). The NYHA class was II (20pts), III (105pts), IV (10pts). The
LVEF was 30 ±8%. The F.U period was 25±15 months
Results: AS occurred in 8 (6%) pts at an average of 18±7 months after
ICD implantation. The mean number of arrhythmic episodes constituting AS
was 25 ±22 (range 6 to 82) per pt. Hospital admission was required for 6 pts.
The presumed causes of AS were: a) deterioration of the clinical status in 5pts,
b) electrolyte disturbances (hypokalemia) in 2pts, c) unknown in 1pt. The
LVEF of pts with AS was 23± 9%(p<0.05). The pts with AS caused by wors-
